
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZNF526 CRISPR/Cas9 KO Plasmid (m) | sc-431684 | 20 µg | $397.00 |
Zfp526 encodes the mouse zinc finger protein ZNF526, a putative nuclear DNA-binding factor implicated in transcriptional regulation through C2H2-type zinc finger–mediated interactions with regulatory elements. As with many KRAB-associated zinc finger proteins, ZNF526 is expected to participate in chromatin-dependent gene silencing and modulation of lineage-specific transcriptional programs that influence cell state and differentiation. Altered expression or dysregulation of zinc finger transcription factors can perturb epigenetic control networks and downstream signaling pathways, providing a framework to study gene regulatory mechanisms relevant to developmental phenotypes and disease-associated transcriptional imbalance. Functional interrogation of Zfp526 supports investigations into how transcription factor–chromatin interfaces shape gene expression and cellular homeostasis in mouse model systems.
ZNF526 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Zfp526 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Zfp526 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Zfp526 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ZNF526 protein expression.
This CRISPR knockout system enables efficient generation of Zfp526-deficient cell models for investigation of ZNF526 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.